Effects of coenzyme Q10 on statin-induced myopathy: A meta-analysis of randomized controlled trials

Mayo Clinic Proceedings

Volumn 90, Issue 1, 2015, Pages 24-34

  Banach, Maciej ^a   Serban, Corina ^b   Sahebkar, Amirhossein ^c   Ursoniu, Sorin ^b   Rysz, Jacek ^a   Muntner, Paul ^d   Toth, Peter P ^f   Jones, Steven R ^f,g   Rizzo, Manfredi ^h   Glasser, Stephen P ^e   Lip, Gregory Y H ⁱ   Dragan, Simona ^b   Mikhailidis, Dimitri P ^j  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e University of Alabama at Birmingham   (United States)

^f CGH Medical Center   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h UNIVERSITY OF PALERMO   (Italy)

ⁱ UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^j ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; UBIDECARENONE; CREATINE KINASE MM; UBIQUINONE; VITAMIN;

ADULT; AGED; ARTICLE; CREATINE KINASE BLOOD LEVEL; DRUG EFFICACY; ENZYME ACTIVITY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MYALGIA; MYOPATHY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHABDOMYOLYSIS; SENSITIVITY ANALYSIS; STATIN INDUCED MYOPATHY; SYSTEMATIC REVIEW; ANALOGS AND DERIVATIVES; BLOOD; CHEMICALLY INDUCED; DIET SUPPLEMENTATION; OUTCOME ASSESSMENT; PAIN MEASUREMENT; PROCEDURES;

CREATINE KINASE, MM FORM; DIETARY SUPPLEMENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYALGIA; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UBIQUINONE; VITAMINS;

EID: 84920471176     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2014.08.021     Document Type: Article

References (44)

1. T.T. Abd, and T.A. Jacobson Statin-induced myopathy: a review and update Expert Opin Drug Saf 10 3 2011 373 387
2. R.S. Rosenson, S.K. Baker, T.A. Jacobson, S.L. Kopecky, and B.A. Parker An assessment by the Statin Muscle Safety Task Force: 2014 update J Clin Lipid 8 3 suppl 2014 S58 S71
3. L. Marcoff, and P.D. Thompson The role of coenzyme Q10 in statin-associated myopathy: a systematic review J Am Coll Cardiol 49 23 2007 2231 2237
4. G.B. Mancini, A.Y. Tashakkor, and S. Baker Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update Can J Cardiol 29 12 2013 1553 1568
5. S.M. Policepatil, R.H. Caplan, and M. Dolan Hypocalcemic myopathy secondary to hypoparathyroidism WMJ 111 4 2012 173 175
6. J. Barber, R.C. Butler, and M.W. Davie Hypoparathyroidism presenting as myopathy with raised creatine kinase Rheumatology (Oxford) 40 12 2001 1417 1418
7. V. Syriou, A. Kolitsa, and L. Pantazi Hypoparathyroidism in a patient presenting with severe myopathy and skin rash: case report and review of the literature Hormones (Athens) 4 3 2005 161 164
8. D.B. Nora, D. Fricke, J. Becker, and I. Gomes Hypocalcemic myopathy without tetany due to idiopathic hypoparathyroidism: case report Arq Neuropsiquiatr 62 1 2004 154 157
9. N.J. Stone, J. Robinson, and A.H. Lichtenstein 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 25, suppl 2 2014 S1 S45
10. F. Taylor, M.D. Huffman, and A.F. Macedo Statins for the primary prevention of cardiovascular disease Cochrane Database Syst Rev 1 2013 CD004816
11. J. Garrido-Maraver, M.D. Cordero, and M. Oropesa-Avila Clinical applications of coenzyme Q10 Front Biosci (Landmark Ed) 19 2014 619 633
12. I. Pravst, K. Žmitek, and J. Žmitek Coenzyme Q10 contents in foods and fortification strategies Crit Rev Food Sci Nutr 50 4 2010 269 280
13. A. Kalen, E.L. Appelkvist, and G. Dallner Age-related changes in the lipid compositions of rat and human tissues Lipids 24 7 1989 579 584
14. G. Tian, J. Sawashita, and H. Kubo Ubiquinol-10 supplementation activates mitochondria functions to decelerate senescence in senescence-accelerated mice Antioxid Redox Signal 20 16 2014 2606 2620
15. A.W. Linnane, G. Kopsidas, and C. Zhang Cellular redox activity of coenzyme Q10: effect of CoQ10 supplementation on human skeletal muscle Free Radic Res 36 4 2002 445 453
16. K. Folkers, P. Langsjoen, and R. Willis Lovastatin decreases coenzyme Q levels in humans Proc Natl Acad Sci U S A 87 22 1990 8931 8934
17. Y. Miyake, A. Shouzu, and M. Nishikawa Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients Arzneimittelforschung 49 4 1999 324 329
18. A.M. Bargossi, G. Grossi, P.L. Fiorella, A. Gaddi, R. Di Giulio, and M. Battino Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors Mol Aspects Med 15 suppl 1994 s187 s193
19. M.A. Silver, P.H. Langsjoen, S. Szabo, H. Patil, and A. Zelinger Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction Am J Cardiol 94 10 2004 1306 1310
20. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, and P. Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Int J Surg 8 5 2010 336 341
21. A.R. Jadad, R.A. Moore, and D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1 1996 1 12
22. D. Moher, D.J. Cook, and A.R. Jadad Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses Health Technol Assess 3 12 1999 i iv 1-98
23. S.P. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med Res Methodol 5 2005 13
24. G. Caso, P. Kelly, M.A. McNurlan, and W.E. Lawson Effect of coenzyme q10 on myopathic symptoms in patients treated with statins Am J Cardiol 99 10 2007 1409 1412
25. D.A. Bookstaver, N.A. Burkhalter, and C. Hatzigeorgiou Effect of coenzyme Q10 supplementation on statin-induced myalgias Am J Cardiol 110 4 2012 526 529
26. J. Fedacko, D. Pella, and P. Fedackova Coenzyme Q(10) and selenium in statin-associated myopathy treatment Can J Physiol Pharmacol 91 2 2013 165 170
27. H. Mabuchi, A. Nohara, and J. Kobayashi Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study Atherosclerosis 195 2 2007 e182 e189
28. J.M. Young, C.M. Florkowski, and S.L. Molyneux Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia Am J Cardiol 100 9 2007 1400 1403
29. M.P. Bogsrud, G. Langslet, and L. Ose No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy Scand Cardiovasc J 47 2 2013 80 87
30. M. Banach, M. Malodobra-Mazur, A. Gluba, N. Katsiki, J. Rysz, and A. Dobrzyn Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevance Curr Pharm Des 19 27 2013 4904 4912
31. N. Katsiki, and M. Banach Statins and the risk of diabetes: the debate Arch Intern Med 172 11 2012 895 896
32. M.F. Beal Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease Parkinsonism Relat Disord 15 suppl 3 2009 S189 S194
33. A. Thibault, D. Samid, and A.C. Tompkins Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer Clin Cancer Res 2 3 1996 483 491
34. M. Needham, and F.L. Mastaglia Statin myotoxicity: a review of genetic susceptibility factors Neuromuscul Disord 24 1 2014 4 15
35. C. Schmelzer, I. Lindner, C. Vock, K. Fujii, and F. Doring Functional connections and pathways of coenzyme Q10-inducible genes: an in-silico study IUBMB Life 59 10 2007 628 633
36. D.A. Groneberg, B. Kindermann, and M. Althammer Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells Int J Biochem Cell Biol 37 6 2005 1208 1218
37. M.A. Eghbal, N. Abdoli, and Y. Azarmi Efficiency of hepatocyte pretreatment with coenzyme Q10 against statin toxicity Arh Hig Rada Toksikol 65 1 2014 101 108
38. M.A. Jimenez-Santos, I.E. Juarez-Rojop, and C.A. Tovilla-Zarate Coenzyme Q10 supplementation improves metabolic parameters, liver function and mitochondrial respiration in rats with high doses of atorvastatin and a cholesterol-rich diet Lipids Health Dis 13 2014 22
39. B.J. Lee, Y.F. Tseng, C.H. Yen, and P.T. Lin Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial Nutr J 12 1 2013 142
40. R.E. Deichmann, C.J. Lavie, and A.C. Dornelles Impact of coenzyme Q-10 on parameters of cardiorespiratory fitness and muscle performance in older athletes taking statins Phys Sportsmed 40 4 2012 88 95
41. M. Wyman, M. Leonard, and T. Morledge Coenzyme Q10: a therapy for hypertension and statin-induced myalgia? Cleve Clin J Med 77 7 2010 435 442
42. I. Buhaescu, and H. Izzedine Mevalonate pathway: a review of clinical and therapeutical implications Clin Biochem 40 9-10 2007 575 584
43. B.A. Parker, S.M. Gregory, L. Lorson, D. Polk, C.M. White, and P.D. Thompson A randomized trial of coenzyme Q10 in patients with statin myopathy: rationale and study design J Clin Lipidol 7 3 2013 187 193
44. J.R. Guyton, H.E. Bays, S.M. Grundy, and T.A. Jacobson An assessment by the Statin Intolerance Panel: 2014 update J Clin Lipidol 8 3 2014 S72 S81